AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Artiva Biotherapeutics, Inc.

$4.19 -$0.04 (-0.95%)
NASDAQ · 30 Oct 2026 20:00 UTC
Previous Close
$4.23
Day Range
$4.10$4.26
Year Range
$2.96$14.53
Market Cap
204.85M
AVG Volume
577.15K
Trailing/Forward PE
-1.27/-
PEG ratio
0.06
Dividend Yield
-
Next Earnings Date
2026-11-11
Primary Exchange
NASDAQUS
Revenue (USD) · A
010M20M30M40M202320242025
ARTV Revenue (USD) by year
PeriodRevenue (USD)
20250
2024251K
202333.49M
Net Income (USD) · A
-100M-75M-50M-25M0202320242025
ARTV Net Income (USD) by year
PeriodNet Income (USD)
2025-83.86M
2024-58.49M
2023-28.72M
Operating Income (USD) · A
-100M-75M-50M-25M0202320242025
ARTV Operating Income (USD) by year
PeriodOperating Income (USD)
2025-89.81M
2024-67.28M
2023-30.67M
EBITDA · A
Cash Flows · A
EPS · A
Expenses · A
Cash & Debt · A
Debt ratios · A
Margins · A
Return on Capital · A
Shares Outstanding · A
Dividends (USD) · A
Employee Count
Book Value Per Share · A
Total Assets · A
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: ARTV

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 11 Nov 2026.

Artiva Biotherapeutics, Inc.
ARTV
Stockpicker

Video analysis: ARTV

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: ARTV

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.